{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:01:25Z","timestamp":1773252085899,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.vaccine.2024.06.038","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T08:07:33Z","timestamp":1718611653000},"page":"126071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Proceedings of the dengue endgame summit: Imagining a world with dengue control"],"prefix":"10.1016","volume":"42","author":[{"given":"Adam D.","family":"Wegman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirin","family":"Kalimuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto T.A.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura E.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan L.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory D.","family":"Gromowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taia T.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Weiskopf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin L.","family":"Hibberd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Alex Perkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca C.","family":"Christofferson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagwat","family":"Gunale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasad S","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Macareo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Yacoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eng","family":"Eong Ooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Paz-Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4536-6714","authenticated-orcid":false,"given":"Adam T.","family":"Waickman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.06.038_b0005","doi-asserted-by":"crossref","first-page":"e0010724","DOI":"10.1371\/journal.pntd.0010724","article-title":"Chronic sequelae complicate convalescence from both dengue and acute viral respiratory illness","volume":"16","author":"Kalimuddin","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.06.038_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10101234","article-title":"Entomological Risk Assessment for Dengue Virus Transmission during 2016\u20132020 in Kamphaeng Phet, Thailand","volume":"10","author":"Fansiri","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2024.06.038_b0015","doi-asserted-by":"crossref","first-page":"e0011270","DOI":"10.1371\/journal.pntd.0011270","article-title":"Seroprevalence of Dengue, Chikungunya and Zika at the epicenter of the congenital microcephaly epidemic in Northeast Brazil: A population-based survey","volume":"17","author":"Braga","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.06.038_b0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coviro.2020.07.008","article-title":"T lymphocyte responses to flaviviruses - diverse cell populations affect tendency toward protection and disease","volume":"43","author":"Sanchez Vargas","year":"2020","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2024.06.038_b0025","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri3014","article-title":"Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms","volume":"11","author":"Rothman","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2024.06.038_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00100-2","article-title":"Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial","author":"Lyke","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.038_b0035","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157811","article-title":"The innate immune response following multivalent dengue vaccination and implications for protection against dengue challenge","volume":"7","author":"Hou","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2024.06.038_b0040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/imr.13109","article-title":"Heterogeneity in IgG-CD16 signaling in infectious disease outcomes","volume":"309","author":"Gonzalez","year":"2022","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2024.06.038_b0045","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.aai8128","article-title":"IgG antibodies to dengue enhanced for Fc\u03b3RIIIA binding determine disease severity","volume":"355","author":"Wang","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.06.038_b0050","doi-asserted-by":"crossref","unstructured":"R.I. Galvez et al., Frequency of Dengue Virus-Specific T Cells is related to Infection Outcome in Endemic Settings. medRxiv, (2024).","DOI":"10.1101\/2024.02.05.24302330"},{"key":"10.1016\/j.vaccine.2024.06.038_b0055","doi-asserted-by":"crossref","first-page":"e0009562","DOI":"10.1371\/journal.pntd.0009562","article-title":"Case-area targeted interventions (CATI) for reactive dengue control: Modelling effectiveness of vector control and prophylactic drugs in Singapore","volume":"15","author":"Brady","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.06.038_b0060","doi-asserted-by":"crossref","first-page":"e1010424","DOI":"10.1371\/journal.pcbi.1010424","article-title":"Fusing an agent-based model of mosquito population dynamics with a statistical reconstruction of spatio-temporal abundance patterns","volume":"19","author":"Cavany","year":"2023","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.vaccine.2024.06.038_b0065","doi-asserted-by":"crossref","unstructured":"M. Palanichamy Kala, A.L. St John, A.P.S. Rathore, Dengue: Update on Clinically Relevant Therapeutic Strategies and Vaccines. Curr Treat Options Infect Dis 2023;15;27-52.","DOI":"10.1007\/s40506-023-00263-w"},{"key":"10.1016\/j.vaccine.2024.06.038_b0070","doi-asserted-by":"crossref","first-page":"e1011616","DOI":"10.1371\/journal.ppat.1011616","article-title":"DENV-specific IgA contributes protective and non-pathologic function during antibody-dependent enhancement of DENV infection","volume":"19","author":"Wegman","year":"2023","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2024.06.038_b0075","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiad122","article-title":"Soluble NS1 antagonizes IgG- and IgA-mediated monocytic phagocytosis of DENV infected cells","author":"Waldran","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.038_b0080","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/s41564-024-01668-z","article-title":"Low-dose dengue virus 3 human challenge model: a phase 1 open-label study","volume":"9","author":"Waickman","year":"2024","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2024.06.038_b0085","doi-asserted-by":"crossref","first-page":"eabo5019","DOI":"10.1126\/scitranslmed.abo5019","article-title":"Evolution of inflammation and immunity in a dengue virus 1 human infection model","volume":"14","author":"Waickman","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2024.06.038_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00030-6","article-title":"An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia","author":"Gunale","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2024.06.038_bib106","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cell.2015.06.057","article-title":"Structure-Guided Design of anAnti-dengue Antibody Directed to a Non-immunodominant Epitope","volume":"162","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2024.06.038_bib107","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.antiviral.2017.05.007","article-title":"Preclinical evaluation of VIS513, a therapeutic antibody against dengue virus, in non-human primates","volume":"144","author":"Ong","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2024.06.038_b0095","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1021\/acs.jmedchem.3c02336","article-title":"Discovery of JNJ-1802, a First-in-class pan-serotype dengue virus NS4B Inhibitor","volume":"67","author":"Kesteleyn","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.vaccine.2024.06.038_b0100","doi-asserted-by":"crossref","first-page":"e0000005","DOI":"10.1371\/journal.pdig.0000005","article-title":"Applied machine learning for the risk-stratification and clinical decision support of hospitalised patients with dengue in Vietnam","volume":"1","author":"Ming","year":"2022","journal-title":"PLOS Digit Health"},{"key":"10.1016\/j.vaccine.2024.06.038_b0105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.47102\/annals-acadmedsg.V42N8p373","article-title":"Dengue\u2013old disease, new challenges in an ageing population","volume":"42","author":"Low","year":"2013","journal-title":"Ann Acad Med Singap"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24007126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24007126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:42:34Z","timestamp":1773182554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24007126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":23,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0264410X24007126"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proceedings of the dengue endgame summit: Imagining a world with dengue control","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"126071"}}